Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - SANDELL SCOTT D
Last Updated 
29-Aug-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

SANDELL SCOTT D: Declared Holdings
Company/RelationshipReportedShares  Ownership
Adaptimmune Therapeutics plc
Beneficial Owner (10% or more)
NasdaqGS:ADAP
(historical quotes, profile, other insiders)
1-Jan-1659,269,000  Indirect
Achaogen, Inc.
Beneficial Owner (10% or more)
NasdaqGM:AKAO
(historical quotes, profile, other insiders)
3-Jun-164,715,128  Indirect
Ardelyx, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ARDX
(historical quotes, profile, other insiders)
18-Jul-1614,084,174  Indirect
AVEO Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:AVEO
(historical quotes, profile, other insiders)
13-May-1610,362,694  Indirect
Box, Inc. Class A Common Stock
Beneficial Owner (10% or more)
NYSE:BOX
(historical quotes, profile, other insiders)
28-Jan-150  Indirect
CVENT, INC. Common Stock
Beneficial Owner (10% or more)
NYSE:CVT
(historical quotes, profile, other insiders)
25-Nov-143,997,754  Indirect
Tableau Software, Inc. Class A
Director
NYSE:DATA
(historical quotes, profile, other insiders)
5-Dec-1455,705  Indirect
Dermira, Inc.
Beneficial Owner (10% or more)
NasdaqGS:DERM
(historical quotes, profile, other insiders)
8-Oct-143,502,922  Indirect
Epizyme, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EPZM
(historical quotes, profile, other insiders)
12-Jan-166,261,502  Indirect
GlycoMimetics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:GLYC
(historical quotes, profile, other insiders)
16-Nov-158,584,128  Indirect
INTERLEUKIN GENETICS
Beneficial Owner (10% or more)
Other OTC:ILIU
(historical quotes, profile, other insiders)
29-Jul-1655,418,811  Indirect
Mirna Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:MIRN
(historical quotes, profile, other insiders)
6-Oct-152,971,517  Indirect
Supernus Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:SUPN
(historical quotes, profile, other insiders)
11-Nov-154,116,086  Indirect
TRACON Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:TCON
(historical quotes, profile, other insiders)
4-Feb-151,888,474  Indirect
TESARO, Inc.
Beneficial Owner (10% or more)
NasdaqGS:TSRO
(historical quotes, profile, other insiders)
18-Mar-1610,275,113  Indirect
Vitae Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:VTAE
(historical quotes, profile, other insiders)
1-Jul-151,788,254  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
29-Jul-16 *20,120,724ILIU Purchase at $0.10 per share.
(Cost of $2,012,072)
18-Jul-16 *2,290,951ARDX Purchase at $8.73 per share.
(Cost of $20,000,002)
3-Jun-16 *4,715,128AKAO Statement of Ownership
13-May-16 *10,362,694AVEO Statement of Ownership
18-Mar-16 *1,420,858TSRO Purchase at $35.19 - $35.19 per share.
(Cost of about $50,000,000)
13-Jan-16 *1,500,000ARDX Purchase at $10 per share.
(Cost of $15,000,000)
12-Jan-16 *1,111,111EPZM Purchase at $9 - $9 per share.
(Cost of about $10,000,000)
1-Jan-16 *59,269,000ADAP Statement of Ownership
16-Nov-15 *452GLYC Sale at $6.91 - $6.91 per share.
(Proceeds of about $3,123)
16-Nov-15 *9,445GLYC Option Exercise at $0.33 - $0.33 per share.
(Cost of about $3,116)
11-Nov-15 *1,468,393SUPN Acquisition (Non Open Market) at $0 per share.
11-Nov-15 *4,993,557SUPN Disposition (Non Open Market) at $0 per share.
6-Oct-15 *289,166MIRN Acquisition (Non Open Market) at $0 per share.
6-Oct-15 *857,142MIRN Purchase at $7 - $7 per share.
(Cost of about $6,000,000)
5-Oct-15 *1,825,209MIRN Acquisition (Non Open Market)
1-Jul-15 *9,940VTAE Acquisition (Non Open Market) at $0 per share.
1-Jul-15 *833,250VTAE Disposition (Non Open Market) at $0 per share.
17-Jun-15 *136,597SUPN Sale at $16.02 - $17.03 per share.
(Proceeds of about $2,257,000)
16-Jun-15 *95,437SUPN Sale at $16.85 - $17.01 per share.
(Proceeds of about $1,616,000)
15-Jun-15 *3,921,000SUPN Disposition (Non Open Market) at $0 per share.
15-Jun-15 *1,153,034SUPN Acquisition (Non Open Market) at $0 per share.
5-Jun-15 *4,672,897ARDX Purchase at $10.70 - $10.7 per share.
(Cost of about $50,000,000)
2-Jun-15 *2,633TSRO Sale at $57.55 - $59.72 per share.
(Proceeds of about $154,000)
1-Jun-15 *12,633TSRO Acquisition (Non Open Market) at $0 per share.
1-Jun-15 *1,010,000TSRO Disposition (Non Open Market) at $0 per share.
4-Feb-15 *500,000TCON Purchase at $10 - $10 per share.
(Cost of about $5,000,000)
4-Feb-15 *1,388,474TCON Acquisition (Non Open Market)
28-Jan-15 *2,091,457BOX Disposition (Non Open Market)
28-Jan-15 *1,928,677BOX Acquisition (Non Open Market)
22-Jan-15 *162,780BOX Statement of Ownership
26-Dec-14 *1,972ARDX Sale at $21.28 - $21.28 per share.
(Proceeds of about $42,000)
23-Dec-14 *19,868,965ILIU Purchase at $0.10 per share.
(Cost of $1,986,896)
23-Dec-14 *10,000ARDX Disposition (Non Open Market) at $0 per share.
23-Dec-14 *2,564ARDX Acquisition (Non Open Market) at $0 per share.
5-Dec-14 *17,123DATA Sale at $81.76 - $81.76 per share.
(Proceeds of about $1,400,000)
4-Dec-14 *34,786DATA Sale at $80.78 - $81.32 per share.
(Proceeds of about $2,819,000)
3-Dec-14 *17,663DATA Sale at $81.48 - $81.48 per share.
(Proceeds of about $1,439,000)
2-Dec-14 *1,633,750DATA Disposition (Non Open Market) at $0 per share.
2-Dec-14 *1,730,428DATA Acquisition (Non Open Market) at $0 per share.
25-Nov-14 *13,143CVT Acquisition (Non Open Market) at $0 per share.
25-Nov-14 *1,010,000CVT Disposition (Non Open Market) at $0 per share.
10-Nov-14 *6,250DATA Disposition (Non Open Market) at $0 per share.
8-Oct-14 *3,416,569DERM Acquisition (Non Open Market) at $0 per share.
8-Oct-14 *69,112DERM Purchase at $16 - $16 per share.
(Cost of about $1,106,000)
2-Oct-14 *17,241DERM Statement of Ownership
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?